- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04055350
Electronically Recorded National Early Warning Scores, Pain Scores and PONV Scores Among Hospitalized Patients
Electronically Recorded National Early Warning Scores, Pain Scores and PONV Scores Among Hospitalized Patients and the Associated Patient Outcomes.
Study Overview
Status
Conditions
Detailed Description
The investigators aim to collect detailed data on patients' vital signs, NEWSs, pain scores and PONV scores through electronic data records, where these values are automatically stored with mobile mobile smart devices used by nursing staff. The expected volume of the cohort is 50,000 patients and 300,000 recordings of vital signs.
In addition to the scores and vital signs, the registry will include patients' identification numbers (IDs), dates and times of the recordings, and ward numbers. With the IDs, mortality data up to 90-days for the patients will be obtained from the national population register centre. All data will be handled in a pseudonymized form in a secure computer inside hospital, and approval to use the registry in study purposes will be obtained from the Ethics Committee of Tampere University Hospital.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Pirkanmaa
-
Tampere, Pirkanmaa, Finland, 33520
- Tampere University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult in-hospital patients with recordings of vital signs
Exclusion Criteria:
- Patients under 18 years
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Death occurring within 90-days of the last NEWS measurement
Time Frame: 90 days
|
The percentage of patients that die within 90-days of the last NEWS recording during their hospitalization.
|
90 days
|
Death occurring within one day after the first NEWS measurement on general wards
Time Frame: One day
|
The percentage of patients that die within one day after their first NEWS measurement at the beginning of their general ward admission
|
One day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Death occurring within 30-days of the last NEWS measurement
Time Frame: 30 days
|
The percentage of patients that die within 30-days of the last NEWS recording during their hospitalization.
|
30 days
|
Death occurring within 2-30 days after the first NEWS measurement on general wards
Time Frame: 2-30 days
|
The percentage of patients that die within 2-30 days after their first NEWS measurement at the beginning of their general ward admission
|
2-30 days
|
Incidence of post operative nausea and vomiting
Time Frame: Up to 30 days after the first recording of patient's vital signs in the electronic patient records
|
Percentage of patients suffering from post-operative nausea and vomiting (recorded as a scale from 0 to 5) in the electronic patient records.
|
Up to 30 days after the first recording of patient's vital signs in the electronic patient records
|
Incidence of post operative pain
Time Frame: Up to 30 days after the first recording of patient's vital signs in the electronic patient records
|
Percentage of patients suffering from post operative pain (recorded as numerical scale from 0 to 10) in the electronic patient records.
|
Up to 30 days after the first recording of patient's vital signs in the electronic patient records
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R20007R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prevention of In-hospital Adverse Events
-
Ochsner Health SystemCompletedHospital Length of Stay; Adverse Events
-
Athens General Children's Hospital "Pan. & Aglaia...CompletedEffect of Anesthesia in Postoperative Pain | Effect of Anesthesia in Extubation Time | Effect of Anesthesia in Discharge Time From Postanesthesia Care Unit | Effect of Anesthesia in Postoperative Adverse Events | Effect of Anesthesia in Discharge Time From the HospitalGreece
-
Nantes University HospitalCompleted
-
Lei DuUnknownRisks of Adverse Events After Cardiac SurgeryChina
-
Lin ZhaoRecruitingIn-stent Restenosis | Major Adverse Cardiovascular EventsChina
-
Medstar Health Research InstituteCompletedIncidence of Major Adverse Cardiac EventsUnited States
-
University Health Network, TorontoCompletedThe Study Focuses on the Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator on Postoperative Pharyngolaryngeal Adverse EventsCanada
-
Insel Gruppe AG, University Hospital BernCharite University, Berlin, Germany; Kantonsspital Aarau; University of Lausanne... and other collaboratorsNot yet recruitingAirway Complication of Anesthesia | Adverse EventsGermany, Switzerland
-
Brigham and Women's HospitalUniversity of Chicago; University of Wisconsin, Madison; University of California... and other collaboratorsCompletedMedication Administered in Error | Adverse Drug EventsUnited States
-
Brigham and Women's HospitalUnknownMedication Administered in Error | Adverse Drug EventsUnited States